Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quercetin for Microvascular Function in Obesity
NCT06683534Phase 2Not yet recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- Jul 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
Phase 2, randomised trial in microvascular dysfunction (MVD) and obesity (2 arms), sponsored by Medical College of Wisconsin. Primary endpoint: Change in blood vessel dilation at 2 hours. Planned start Jul 2026; status: not yet recruiting.
02
Conditions
microvascular dysfunction (MVD)obesity
Beyond the preview
Go deeper on NCT06683534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06683534.